Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pidilizumab in Chronic Hepatitis C
NCT00962936Phase 2Terminated
- Sponsor
- CureTech
- Start
- Sep 2009
- Primary completion
- Oct 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of pidilizumab in hepatitis C (HCV), sponsored by CureTech. Started Sep 2009; status: terminated.
02
Drugs
pidilizumab
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00962936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00962936.